CHE Chemed Corporation
Healthcare$439.36-0.50%ClosedMarket Cap: $5.83B
As of 2026-05-25
Analyst Consensus
Consensus
Hold
Target (Consensus)
$475.00
Target (Median)
$475.00
Target Range
$475.00 - $475.00
Upside from current price: 8.1%
Rating Distribution
0 Strong Buy1 Buy3 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-04-27 | RBC Capital | maintain | Sector Perform | Sector Perform |
| 2026-02-27 | Oppenheimer | maintain | Outperform | Outperform |
| 2026-02-27 | RBC Capital | downgrade | Sector Perform | Outperform |
| 2026-01-22 | Jefferies | downgrade | Hold | Buy |
| 2025-11-10 | RBC Capital | maintain | Outperform | Outperform |
| 2025-09-10 | B of A Securities | maintain | Buy | Buy |
| 2025-09-02 | Jefferies | upgrade | Buy | Hold |
| 2025-07-31 | Oppenheimer | maintain | Outperform | Outperform |
| 2025-07-31 | RBC Capital | maintain | Outperform | Outperform |
| 2025-06-30 | B of A Securities | maintain | Buy | Buy |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Wed Dec 31 | $22.15 | $2.55B | 3 |
| Thu Dec 31 | $24.35 | $2.69B | 2 |
| Fri Dec 31 | $26.91 | $2.86B | 2 |
| Sun Dec 31 | $28.85 | $3.01B | 1 |